Cesar S. Fuziwara
Sao Paulo, SP 04044020, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer.
Journal: International journal of molecular sciences
Published: June 02, 2026
Dual Effect of EZH2 Gene Editing with CRISPR/Cas9 in Lung Cancer.
Journal: Biology
Published: January 07, 2026
Editorial: New molecular pathways in thyroid biology: role of coding and noncoding genes in thyroid pathophysiology, volume II.
Journal: Frontiers in endocrinology
Published: October 21, 2025
Tertiary lymphoid structures in thyroid cancer.
Journal: Archives of endocrinology and metabolism
Published: September 26, 2025
Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome.
Journal: Molecular therapy. Nucleic acids
Published: September 20, 2025
Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma.
Journal: Cells
Published: April 26, 2024
Editorial: New molecular pathways in thyroid cancer and pathophysiology: role of coding and noncoding genes.
Journal: Frontiers in endocrinology
Published: March 20, 2024
Modulating gene expression as a strategy to investigate thyroid cancer biology.
Journal: Archives of endocrinology and metabolism
Published: February 15, 2024
Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line.
Journal: Advances in experimental medicine and biology
Published: July 24, 2023
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer.
Journal: International journal of molecular sciences
Published: February 28, 2023
Last Updated: 09/26/2026